Cargando…
Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability
Designing useful functionalities in clinically validated, old antibiotics holds promise to provide the most economical solution for the global lack of effective antibiotics, as undoubtedly a serious health threat. Here we show that using the surface chemistry of the cyclodextrin (βCD) cycle and argi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653501/ https://www.ncbi.nlm.nih.gov/pubmed/36371541 http://dx.doi.org/10.1038/s42003-022-04197-9 |
_version_ | 1784828699999207424 |
---|---|
author | Vukomanovic, Marija Gazvoda, Lea Kurtjak, Mario Hrescak, Jitka Jaklic, Blaž Moya-Andérico, Laura Cendra, Maria del Mar Torrents, Eduard |
author_facet | Vukomanovic, Marija Gazvoda, Lea Kurtjak, Mario Hrescak, Jitka Jaklic, Blaž Moya-Andérico, Laura Cendra, Maria del Mar Torrents, Eduard |
author_sort | Vukomanovic, Marija |
collection | PubMed |
description | Designing useful functionalities in clinically validated, old antibiotics holds promise to provide the most economical solution for the global lack of effective antibiotics, as undoubtedly a serious health threat. Here we show that using the surface chemistry of the cyclodextrin (βCD) cycle and arginine (arg) as a linker, provides more stable ternary antibiotic complex (βCD-arg-cpx). In contrast to classical less stable inclusion complexes, which only modify antibiotic solubility, here-presented ternary complex is more stable and controls drug release. The components of the complex intensify interactions with bacterial membranes and increase the drug’s availability inside bacterial cells, thereby improving its antimicrobial efficacy and safety profile. Multifunctional antibiotics, formulated as drug delivery systems per se, that take the drug to the site of action, maximize its efficacy, and provide optical detectability are envisaged as the future in fighting against infections. Their role as a tool against multiresistant strains remains as interesting challenge open for further research. |
format | Online Article Text |
id | pubmed-9653501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96535012022-11-15 Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability Vukomanovic, Marija Gazvoda, Lea Kurtjak, Mario Hrescak, Jitka Jaklic, Blaž Moya-Andérico, Laura Cendra, Maria del Mar Torrents, Eduard Commun Biol Article Designing useful functionalities in clinically validated, old antibiotics holds promise to provide the most economical solution for the global lack of effective antibiotics, as undoubtedly a serious health threat. Here we show that using the surface chemistry of the cyclodextrin (βCD) cycle and arginine (arg) as a linker, provides more stable ternary antibiotic complex (βCD-arg-cpx). In contrast to classical less stable inclusion complexes, which only modify antibiotic solubility, here-presented ternary complex is more stable and controls drug release. The components of the complex intensify interactions with bacterial membranes and increase the drug’s availability inside bacterial cells, thereby improving its antimicrobial efficacy and safety profile. Multifunctional antibiotics, formulated as drug delivery systems per se, that take the drug to the site of action, maximize its efficacy, and provide optical detectability are envisaged as the future in fighting against infections. Their role as a tool against multiresistant strains remains as interesting challenge open for further research. Nature Publishing Group UK 2022-11-12 /pmc/articles/PMC9653501/ /pubmed/36371541 http://dx.doi.org/10.1038/s42003-022-04197-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Vukomanovic, Marija Gazvoda, Lea Kurtjak, Mario Hrescak, Jitka Jaklic, Blaž Moya-Andérico, Laura Cendra, Maria del Mar Torrents, Eduard Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability |
title | Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability |
title_full | Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability |
title_fullStr | Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability |
title_full_unstemmed | Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability |
title_short | Development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability |
title_sort | development of a ternary cyclodextrin–arginine–ciprofloxacin antimicrobial complex with enhanced stability |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653501/ https://www.ncbi.nlm.nih.gov/pubmed/36371541 http://dx.doi.org/10.1038/s42003-022-04197-9 |
work_keys_str_mv | AT vukomanovicmarija developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability AT gazvodalea developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability AT kurtjakmario developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability AT hrescakjitka developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability AT jaklicblaz developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability AT moyaandericolaura developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability AT cendramariadelmar developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability AT torrentseduard developmentofaternarycyclodextrinarginineciprofloxacinantimicrobialcomplexwithenhancedstability |